These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22971785)

  • 21. Molecular switches under TGFβ signalling during progression from cardiac hypertrophy to heart failure.
    Heger J; Schulz R; Euler G
    Br J Pharmacol; 2016 Jan; 173(1):3-14. PubMed ID: 26431212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matricellular proteins: new molecular targets to prevent heart failure.
    Okamoto H; Imanaka-Yoshida K
    Cardiovasc Ther; 2012 Aug; 30(4):e198-209. PubMed ID: 21884011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
    Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging therapeutic targets in chronic heart failure: part II.
    Roenicke V; Leclair S; Hoffmann A; Becker M; Szado T; Kirsch T; Stoss O; Navé BT; Henkel T
    Expert Opin Ther Targets; 2003 Feb; 7(1):49-59. PubMed ID: 12556202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.
    Guo D; Kassiri Z; Basu R; Chow FL; Kandalam V; Damilano F; Liang W; Izumo S; Hirsch E; Penninger JM; Backx PH; Oudit GY
    Circ Res; 2010 Nov; 107(10):1275-89. PubMed ID: 20847309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcellular remodeling as a viable target for the treatment of congestive heart failure.
    Dhalla NS; Dent MR; Tappia PS; Sethi R; Barta J; Goyal RK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):31-45. PubMed ID: 16703218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologic rationale for the use of beta-blockers in the treatment of heart failure.
    Sabbah HN
    Heart Fail Rev; 2004 Apr; 9(2):91-7. PubMed ID: 15516856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem Cell and Left Ventricular Assist Device Combination Therapy.
    Poglajen G; Gregoric ID; Radovancevic R; Vrtovec B
    Circ Heart Fail; 2019 Feb; 12(2):e005454. PubMed ID: 30759999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy during cardiac remodeling.
    Nishida K; Otsu K
    J Mol Cell Cardiol; 2016 Jun; 95():11-8. PubMed ID: 26678624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats.
    Oie E; Bjørnerheim R; Clausen OP; Attramadal H
    Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H2115-23. PubMed ID: 10843911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure.
    Hanna A; Frangogiannis NG
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):849-863. PubMed ID: 32902739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical role of Rho-kinase pathway for cardiac performance and remodeling in failing rat hearts.
    Kobayashi N; Horinaka S; Mita S; Nakano S; Honda T; Yoshida K; Kobayashi T; Matsuoka H
    Cardiovasc Res; 2002 Sep; 55(4):757-67. PubMed ID: 12176125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocyte changes in heart failure.
    Savinova OV; Gerdes AM
    Heart Fail Clin; 2012 Jan; 8(1):1-6. PubMed ID: 22108722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure.
    Schram K; Sweeney G
    Trends Cardiovasc Med; 2008 Aug; 18(6):199-205. PubMed ID: 19185809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac βarrestin2 Improves Contractility and Adverse Remodeling in Heart Failure, But Is Underexpressed in Humans.
    McCrink KA; Maning J; Vu A; Jafferjee M; Marrero C; Brill A; Bathgate-Siryk A; Dabul S; Koch WJ; Lymperopoulos A
    J Am Coll Cardiol; 2017 Dec; 70(23):2948-2949. PubMed ID: 29216991
    [No Abstract]   [Full Text] [Related]  

  • 37. Integrin expression during reverse remodeling in the myocardium of heart failure patients.
    Dullens HF; Schipper ME; van Kuik J; Sohns W; Scheenstra M; van Wichen DF; Van Oosterhout MF; de Jonge N; de Weger RA
    Cardiovasc Pathol; 2012; 21(4):291-8. PubMed ID: 22100988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
    Creemers EE; Pinto YM
    Cardiovasc Res; 2011 Feb; 89(2):265-72. PubMed ID: 20880837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure: Part I].
    Sirico D; Salzano A; Celentani D; Arcopinto M; Marra AM; Bobbio E; Russo A; Giallauria F; Vigorito C
    Monaldi Arch Chest Dis; 2014 Dec; 82(4):187-94. PubMed ID: 26562984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.